Needle to needle robot‐assisted manufacture of cell therapy products

Needle to needle robot‐assisted manufacture of cell therapy products

Abstract Advanced therapeutic medicinal products (ATMPs) have emerged as novel therapies for untreatable diseases, generating the need for large volumes of high‐quality, clinically‐compliant GMP cells to replace costly, high‐risk and limited scale manual expansion processes. We present the design of...

Full description

Bibliographic Details
Main Authors: Jelena Ochs, Mariana P. Hanga, Georgina Shaw, Niamh Duffy, Michael Kulik, Nokilaj Tissin, Daniel Reibert, Ferdinand Biermann, Panagiota Moutsatsou, Shibani Ratnayake, Alvin Nienow, Niels Koenig, Robert Schmitt, Qasim Rafiq, Christopher J. Hewitt, Frank Barry, J. Mary Murphy
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Bioengineering & Translational Medicine
Subjects:
automation: bioreactors
cell therapy
human stem cells
manufacturing
Online Access:https://doi.org/10.1002/btm2.10387

Internet

https://doi.org/10.1002/btm2.10387

Similar Items